• Blog
  • News
  • All services
  • EN
  • EN
  • +34 91 277 10 76
  • Contact us
logo
  • Azierta
    • About Us
    • Meet Our Team
    • Contact us
  • Services
    • Pharmacovigilance
      • ICSR Management
      • EudraVigilance Registration & Support
      • XEVMPD, Art. 57
      • Safety Reports
      • Signal Detection
      • QPPV support
      • Pharmacovigilance Quality system
      • PSMF and Pharmacovigilance agreements
      • Vigilazierta: Safety database
    • Regulatory Affairs
      • Products registration
      • Dossiers compilation
      • Post-authorization support
      • IDMP – Identification of Medicinal Products
      • Veterinary Medicines Regulation Services
    • GxP Compliance & Safety
      • Toxicological Evaluation of Impurities and Risk Analysis
      • Toxicology reports
      • Biosafety Support
      • REACH Compliance Support- CLP
      • GxP Support: Advice & Implementation of Quality Systems
      • ISO Compliance Support
      • Medical Cannabis Consultancy
    • Digital, Science & Growth
      • Digital Strategy
      • Content Marketing
      • Software Solutions
      • Data & Analytics
    • Audit & Certification
      • GxP Audits
      • Supplier Audit Reports
      • Clinical Analysis Laboratories Audits
      • Audits for Compliance of Medical Devices
      • Medical Cannabis Audits
      • Data Integrity Audits
      • Internal Audits
    • Azierta Care
      • Cosmetics
      • Food Supplements
      • Medical Devices
    • Strategy & Intelligence
      • Life Science Investment Consulting
      • Life Science Business Development
      • Next Generation Regulatory Intelligence
      • Translational Medicine and Clinical Development
      • Next-generation Medical Affairs
  • Integrated Programs
    • Animal Health
    • Biopharma
    • Climate & Environmental
    • Quality Management System
    • Landing in Europe
    • Medical Cannabis
    • Removal of Titanium dioxide
    • Vigilazierta: Safety Database
  • Careers
  • Azierta Associates
    • Auditors Cloud
  • Academy
  • Contact Us
  • e-Consulting
e-Consulting
logo
logo

EMA

  • Home  
  • EMA
Medical Devices
  • January 15, 2020
  • /
  • By azierta
  • /
  • 0 Comments

Brexit: Plazo de adecuación del etiquetado y
las instrucciones de uso de Productos Sanitarios

Ante la salida del Reino Unido de la Unión Europea (EU), la Agencia Europea del Medicamento (EMA) junto con las agencias nacionales, están llevando acabo acciones para garantizar el abastecimiento del mercado europeo en términos de calidad, seguridad y eficacia. A principios de abril, la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), informó sobre […]

READ MORE

Search

Categories

  • All
  • Animal Health
  • Audit & Certification
  • Azierta
  • Cannabis
  • Cosmetics
  • Food Supplements
  • GxP Compliance & Safety
  • Landing in Europe
  • Medical Devices
  • News
  • Pharmacovigilance
  • Quality
  • Regulatory Affairs
  • Toxicology

Latest posts

  • New Annex 1 GMP Sterile
  • Is your xEVMPD database ready?
  • Update Annex 1: Manufacture of Sterile Medicinal Products
    Key criteria to be considered
  • Update Annex 1: Manufacture of Sterile Medicinal Products
    Key criteria to be considered
  • Main Changes revision ICH Q3D (R2) on elemental impurities guideline

Contact Details

  • Call Us : +34 91 277 10 76
  • Mail us : submit a query

Recent Post

October 26, 2022

New Annex 1 GMP Sterile

Read More from Blog

Certified By:

Azierta´s certifications Azierta´s veeva certifications
© 2023 Azierta Contract Science Support Consulting, All Rights Reserved.
    Cookies policy | Privacy policy | Quality policy | Legal Notice